insulin lispro + exenatide (Adocia)

N/A

Report date: 2025/01/26 15:53:31

Base Information

Drug Nameinsulin lispro + exenatide (Adocia)
Drug Alias NameBioChaperone Lispro Exenatide
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsInsulin ligandInsulin receptor agonists
TargetsGlucagon-like peptide 1 receptorInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdocia
China Registration ClassN/A

Develop Information

Active CompaniesAdocia
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A